Cite
HARVARD Citation
Dastani, M. et al. (2023). Three months of combination therapy with nano‐curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: Evidence of a randomized, double‐blinded, placebo‐controlled clinical trial. BioFactors. pp. 108-118. [Online].